Please login to the form below

Not currently logged in


This page shows the latest HPV news and features for those working in and with pharma, biotech and healthcare.

MSD supports Jabs for the Boys campaign

MSD supports Jabs for the Boys campaign

MSD supports Jabs for the Boys campaign. Awards HPV Action an educational grant for its HPV awareness work. ... contact and although condoms may reduce the risk of catching the infection, safe sex cannot complete prevent HPV.

Latest news

More from news
Approximately 5 fully matching, plus 99 partially matching documents found.

Latest Intelligence

  • Immunisation politicised Immunisation politicised

    sexually transmitted human papilloma virus (HPV), including strains that lead to cervical cancer. ... to do so, Austria became a 'European frontrunner' in gender-neutral HPV vaccination.

  • Deal Watch December 2015 Deal Watch December 2015

    200. Bavarian Nordic (DK). Janssen. Collaboration, licence. Vaccine platform technology for development of treatment for cancers induced by HPV.

  • Pharma deals in August 2015 Pharma deals in August 2015

    virus. INO-3112 generates killer T-cell responses to HPV 16 and 18 driven tumours and is in phase I / II clinical studies for cervical and head and neck cancers.

  • Mapping KOL relationships Mapping KOL relationships

    In HPV, for example, influencers include virologists, immunologists, pathologists and epidemiologists.

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    Diovan. valsartan. Novartis. Hypertension. 4. Cervarix. human papillomavirus (HPV) vaccine. GlaxoSmithKline. ... HPV. 5. Lipitor. atorvastatin. Pfizer. Cholesterol lowerer. IMS Health Japan (July to September 2011, Q3).

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...